scispace - formally typeset
S

Sudeep Tanwar

Researcher at Nirma University of Science and Technology

Publications -  410
Citations -  11253

Sudeep Tanwar is an academic researcher from Nirma University of Science and Technology. The author has contributed to research in topics: Computer science & Smart grid. The author has an hindex of 43, co-authored 263 publications receiving 5402 citations. Previous affiliations of Sudeep Tanwar include Bharat Institute of Technology & University Institute of Technology, Burdwan University.

Papers
More filters
Journal ArticleDOI

EVBlocks: A Blockchain-Based Secure Energy Trading Scheme for Electric Vehicles underlying 5G-V2X Ecosystems

TL;DR: A consensus algorithm Proof-of-Greed (PoG) is proposed that handles fluctuations in charging/discharging EVs through an event-driven scheduling mechanism and suggests the proposed scheme is efficient as compared to existing state- of-the-art approaches against compared parameters.
Proceedings ArticleDOI

Block6Tel: Blockchain-based Spectrum Allocation Scheme in 6G-envisioned Communications

TL;DR: In this article, the authors proposed a scheme, Block6Tel, that integrates blockchain in 6G-envisioned spectrum allocation to ensure secure and trusted band allocation among telecom providers, and ensure transparency among telecom stakeholders.
Journal ArticleDOI

Blockchain for Diamond Industry: Opportunities and Challenges

TL;DR: This article surveyed the adoption of BC in the diamond industry, and also present pros and cons of this integration, and presents a case study on frameworks, such as Everledger and Tracr, which highlights the real-time challenges of integrating BC inThe diamond Industry.
Journal ArticleDOI

Taxonomy of secure data dissemination techniques for IoT environment

TL;DR: A comprehensive review on the state-of-the-art techniques, which can verify and validate the performance of data dissemination schemes for IoT networks using relevant parameters, and presents a solution taxonomy of various verification and validation methods.
Journal ArticleDOI

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure

TL;DR: The use of triple-therapy, pegylated-interferon, ribavirin and either of the first generation hepatitis C virus (HCV) protease inhibitors telaprevir or boceprevir, is the new standard of care for treating genotype 1 chronic HCV, but there is limited data from the use of this combination outside this setting.